[PDF][PDF] Rebound in sexually transmitted infections following the success of antiretrovirals for HIV/AIDS.
V Soriano, J Del Romero - AIDS reviews, 2018 - researchgate.net
Nearly 1 million people become infected every day with any of the four major curable
sexually transmitted infections (STIs), namely trichomoniasis, chlamydia, gonorrhea, and …
sexually transmitted infections (STIs), namely trichomoniasis, chlamydia, gonorrhea, and …
Human T-lymphotropic virus type 1 infection and disease in Spain
C de Mendoza, E Caballero, A Aguilera, S Requena… - AIDS, 2017 - journals.lww.com
Human T-lymphotropic virus type 1 (HTLV-1) infection is a neglected disease despite
roughly 15 million people are chronically infected worldwide. Lifelong less than 10% of …
roughly 15 million people are chronically infected worldwide. Lifelong less than 10% of …
Drug interactions in HIV-infected patients treated for hepatitis C
V Soriano, P Labarga… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: The introduction of direct-acting antivirals (DAA) has revolutionized the
hepatitis C field. Most hepatitis C patients can now be cured, including those coinfected with …
hepatitis C field. Most hepatitis C patients can now be cured, including those coinfected with …
New hepatitis C therapies for special patient populations
V Soriano, P Labarga, C de Mendoza… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Chronic hepatitis C virus (HCV) infection has become a curable disease. More
than 90% sustained virologic response rates have been obtained with 8–24 weeks of …
than 90% sustained virologic response rates have been obtained with 8–24 weeks of …
Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C
Introduction: The fixed-dose combination of three direct-acting antivirals (DAA), namely
sofosbuvir, velpatasvir and voxilaprevir is the first pangenotypic, single tablet regimen …
sofosbuvir, velpatasvir and voxilaprevir is the first pangenotypic, single tablet regimen …
Dual antiviral therapy for HIV and hepatitis C–drug interactions and side effects
I Esposito, P Labarga, P Barreiro… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Roughly 20% of HIV-positive persons worldwide are coinfected with hepatitis C
virus (HCV). The recent advent of direct-acting antivirals (DAA) that cure most hepatitis C …
virus (HCV). The recent advent of direct-acting antivirals (DAA) that cure most hepatitis C …
Human T-Lymphotropic Virus Infection in Hepatitis C Virus–Antibody Positive Patients in Spain
A Treviño, A Aguilera, M Rodríguez-Iglesias… - AIDS Research and …, 2017 - liebertpub.com
Since hepatitis C virus (HCV) and human T-lymphotropic virus (HTLV) share transmission
routes, dual infection could be frequent. In Spain, HTLV underdiagnosis is highlighted by the …
routes, dual infection could be frequent. In Spain, HTLV underdiagnosis is highlighted by the …